Cargando…

In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study

Ultraviolet light enhances the generation of reactive oxygen species that are responsible for skin photoageing. The aim of this randomized, vehicle‐ and active‐controlled double‐blind, intra‐individual monocentric study was to evaluate in situ the antioxidant activity of a dermo‐cosmetic product in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribet, Virginie, Nobile, Vincenzo, Rossi, Ana Beatris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973136/
https://www.ncbi.nlm.nih.gov/pubmed/31309627
http://dx.doi.org/10.1111/exd.14005
_version_ 1783489984222724096
author Ribet, Virginie
Nobile, Vincenzo
Rossi, Ana Beatris
author_facet Ribet, Virginie
Nobile, Vincenzo
Rossi, Ana Beatris
author_sort Ribet, Virginie
collection PubMed
description Ultraviolet light enhances the generation of reactive oxygen species that are responsible for skin photoageing. The aim of this randomized, vehicle‐ and active‐controlled double‐blind, intra‐individual monocentric study was to evaluate in situ the antioxidant activity of a dermo‐cosmetic product in photoaged skin. Twenty healthy volunteers had defined skin areas randomized to receive a topical product containing 3 antioxidants (pre‐tocopheryl(®), retinaldehyde and glycylglycine ole‐amide), its vehicle and a positive antioxidant control cream. The products were applied daily for 30‐day period. The skin areas were exposed to a controlled dose of UVA rays, and the skin oxidative status was evaluated 4 and 24 hours post‐UVA exposure at D0 (basal value) and after 15 and 30 days of product application. Skin layers were collected by stripping, and antioxidant capacity was measured using the ferric reducing ability of a plasma assay. Lipid peroxidation (LPO) was assessed using the malonyldialdehyde test. The tested product significantly improved the skin antioxidant capacity after 15 and 30 days and significantly decreased the basal level of the skin LPO. The skin LPO level significantly decreased 4 and 24 hours after UVA exposure at 15 and 30 days. These findings were comparable to positive control treated sites and were significantly different from the vehicle and untreated sites. This minimally invasive methodology enabled a quantitative evaluation of potent antioxidant activity in situ in the stratum corneum reflecting real‐life skin conditions and confirming the benefits of the topical application of a product containing 3 antioxidants in the prevention of UVA‐induced oxidative damage.
format Online
Article
Text
id pubmed-6973136
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69731362020-01-27 In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study Ribet, Virginie Nobile, Vincenzo Rossi, Ana Beatris Exp Dermatol Original Articles Ultraviolet light enhances the generation of reactive oxygen species that are responsible for skin photoageing. The aim of this randomized, vehicle‐ and active‐controlled double‐blind, intra‐individual monocentric study was to evaluate in situ the antioxidant activity of a dermo‐cosmetic product in photoaged skin. Twenty healthy volunteers had defined skin areas randomized to receive a topical product containing 3 antioxidants (pre‐tocopheryl(®), retinaldehyde and glycylglycine ole‐amide), its vehicle and a positive antioxidant control cream. The products were applied daily for 30‐day period. The skin areas were exposed to a controlled dose of UVA rays, and the skin oxidative status was evaluated 4 and 24 hours post‐UVA exposure at D0 (basal value) and after 15 and 30 days of product application. Skin layers were collected by stripping, and antioxidant capacity was measured using the ferric reducing ability of a plasma assay. Lipid peroxidation (LPO) was assessed using the malonyldialdehyde test. The tested product significantly improved the skin antioxidant capacity after 15 and 30 days and significantly decreased the basal level of the skin LPO. The skin LPO level significantly decreased 4 and 24 hours after UVA exposure at 15 and 30 days. These findings were comparable to positive control treated sites and were significantly different from the vehicle and untreated sites. This minimally invasive methodology enabled a quantitative evaluation of potent antioxidant activity in situ in the stratum corneum reflecting real‐life skin conditions and confirming the benefits of the topical application of a product containing 3 antioxidants in the prevention of UVA‐induced oxidative damage. John Wiley and Sons Inc. 2019-09-30 2019-11 /pmc/articles/PMC6973136/ /pubmed/31309627 http://dx.doi.org/10.1111/exd.14005 Text en © 2019 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Ribet, Virginie
Nobile, Vincenzo
Rossi, Ana Beatris
In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study
title In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study
title_full In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study
title_fullStr In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study
title_full_unstemmed In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study
title_short In situ antioxidant activity of a dermo‐cosmetic product: A randomized controlled clinical study
title_sort in situ antioxidant activity of a dermo‐cosmetic product: a randomized controlled clinical study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973136/
https://www.ncbi.nlm.nih.gov/pubmed/31309627
http://dx.doi.org/10.1111/exd.14005
work_keys_str_mv AT ribetvirginie insituantioxidantactivityofadermocosmeticproductarandomizedcontrolledclinicalstudy
AT nobilevincenzo insituantioxidantactivityofadermocosmeticproductarandomizedcontrolledclinicalstudy
AT rossianabeatris insituantioxidantactivityofadermocosmeticproductarandomizedcontrolledclinicalstudy